| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-145555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2004-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c47f9737f99afff6b64982f0f651f779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a76ca4655eca083189faaed1d8c5f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1281e52ba0de4dcfd9c7e18f7d906e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f3f325dee973e6ea01d31735dcd0ecf |
| publicationDate |
2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7648825-B2 |
| titleOfInvention |
Biomarkers for differentiating between type 1 and type 2 diabetes |
| abstract |
Biomarkers that are diagnostic of type 1 diabetes, type 2 diabetes and/or diabetic disorder are identified. Detection of different biomarkers of the invention are also diagnostic of the degree of severity of type 1 diabetes, type 2 diabetes and/or diabetic disorder. An analysis includes the parameters of matching for BMI and Tanner stage. Receiver-operator characteristic (ROC) curves were established to assess association of the biomarkers with a disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010197596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9250225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010267052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10175233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951382-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009155826-A1 |
| priorityDate |
2003-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |